This email came in today from Mark Skousen, and since it’s a quick and dirty one I thought I’d throw it into the mix for y’all. Skousen’s Hedge Fund Trader, which is what’s being advertised here, is predicting that this Brazilian company will report earnings on October 25 and blow the market away. Now, before […]
Articles
- Most Relevant
- Most Recent
I have finally gotten around to editing the spreadsheet to add some consistency, and to update with all the teaser stocks I’ve written about through the end of January. The bad news? If you have invested in each one of those stocks
The following was submitted by loyal Gumshoe reader and Irregular Streetsifter, who has solved and written up a few for us before. Your friendly Gumshoe has done almost no editing, so this is Streetsifter’s work through and through … thanks! Using their words, a “measly dollar” will buy you the solution to the two matching […]
Happy Friday! Here’s the pitch from Yiannis Mostrous that got me interested today: “… the population of children aged zero to 14 has decreased steadily year after year… “… yet sales of children’s products have exploded—from USD 11 billion in 2005 to USD 30 billion in 2009. “This apparent disconnect is the direct result of […]
This one came in from a reader, who also proposed a solution to the teaser (like so many of my readers, he’s a wise one … and he’s right) . This is from an ad from the Half-Priced Stocks newsletter, and if you actually follow through to the ad sell it gets a little sad […]
This one was sent in by a reader, along with a suggestion for the solution (which, as so often with the Gumshoe’s readers, appears to be correct). It’s from Mark Skousen in the form of an ad for Forecasts and Strategies, and, as you have guessed from the title of this note, it’s about a […]
This one’s a little bit different, since the Motley Fool is selling not a subscription necessarily, but a special report called “The NEW Rule Makers: 5 Power Stocks You’ll Never Want to Sell.” Rule Makers is an old term from the Motley Fool lexicon, they’re the ideal evolution from the “Rule Breakers” that Dave Gardner […]
Well here we are, just a day or two after checking out Robert Hsu’s latest solar teaser and we’ve got another one for solar. No surprise, I suppose, when oil seems permanently stuck over $80 a barrel it’s certainly true that solar and all other alternative energy plays are getting even more attention than they […]
As we endure the subprime contagion and all that appears to imply — snakes raining from the heavens, baffled bankers panhandling on the streets with signs saying “will mark to model for food,” and the decline of all stock markets everywhere forever and ever, it’s interesting (though perhaps cruel) to note the newsletter advisers who […]
This one has been around for quite some time, but I thought many of my newer Gumshoe friends might have missed it. It’s a teaser for Agora’s Outstanding Investments newsletter — which is their cheapest one at $49 a year. But hey, even at $49 a year, why pay if you don’t want the newsletter? […]
Don’t worry, this is not about turtle soup, or about chopping up leatherbacks and making acne cream out of them … this is about a whole different kind of sea turtle. The “Hai Gui” or “sea turtles” of China are the returning scientists and businessmen that are driving, in part, the resurgence of the Chinese […]
Most of us might not have heard of Georges Yared a year ago, but any individual investor with an email address will have a hard time avoiding him now — his is one of the latest investment newsletters launched by InvestorPlace Media, the folks who make sure we all know about newsletter advisers Robert Hsu, […]
It seems as though interest in China is again growing, after a Fall and Winter when even rabid China bulls like Robert Hsu were somewhat cautiously looking for “greater China” opportunities and China resource plays in places like Brazil and Australia. Now, it seems, China is cheap enough to be back on the radar — […]
For those of you who haven’t been with the Gumshoe since day one, you’ll probably notice that there are a lot of these teaser emails that come up again, and again, and again. Sometimes the email changes a little bit, sometimes they just update the stock prices in the teasers, sometimes there’s a new hook […]
The world of newsletter email advertising is a big one, with lots of money swirling around, but it’s not all that complicated. You can see the same triggers bring about the same effect time and time again. And one of the biggest triggers for many investors is the price of oil — high oil prices, […]
Another week of fussing about macro issues that we can neither control nor predict, what fun! The Federal Reserve did exactly what the market demanded in cutting rates, but the market was still mad because they failed to promise that they would give us each a pony. President Trump seemed angered by the lack of […]
Most of us are quite familiar with investment newsletters and trading services. I focus on the newsletters that advertise heavily to retail investors, and the most successful type of ad is apparently the “teaser” letter, a well-argued case for a particular stock or investment … that withholds the actual name and ticker until you throw […]
Hi folks — just a quick note to let you know that I have updated the Stock Gumshoe Tracking Spreadsheet and brought it in to the fold as part of the main site, so you can now find it linked from the “Tracking” tab at the top of the page. I will continue to updated […]
This year has been as remarkable as any I can remember — certainly as an investor, but also as a citizen. I remain flabbergasted at the things that have come to pass, and (as is obviously quite clear from the stocks I’ve chosen to profile over the past 10 months) I certainly wouldn’t have predicted […]
Well, I have consistently failed to keep up with my originally planned “monthly updates” on the teaser companies we sleuth out here, but better late than never — let’s take a look at how they’re doing. I have a standing offer, by the way, for anyone who wants to get into the spreadsheet and do […]
Edited by Robert Hsu, this newsletter recommends “pan-Asian” stocks that should profit from the rise of China and its neighbors.
Edited by Robert Hsu, this services recommends stocks of Chinese or China-focused companies.
Most of us are quite familiar with investment newsletters and trading services. I focus on the newsletters that advertise heavily to retail investors, and the most successful type of ad is apparently the “teaser” letter, a well-argued case for a particular stock or investment … that withholds the actual name and ticker until you throw […]
This ad came in fast and hard over the weekend, behind the full marketing might of the folks at Investorplace in service of Asia Edge, Robert Hsu’s more expensive pan-Asia newsletter. And it looks like they’re using some of the tested and (one assumes) successful marketing strategies that got Louis Navellier a lot of attention […]
Robet Hsu is out with a new little tease for us, and he thinks China will continue to be the one remaining bright spot in world economic growth. Of course, his two investment newsletters (China Strategy and Asia Edge) depend on China and its neighbors exciting investors, so that’s no surprise. He was one of […]
I just got an ad from Stephen Leeb for his Aggressive Trader service, and it says that the collapse of Intel shares has unfairly dragged down another tech stock, a hardware company that makes accessories. Though he often uses options for this rapid trading service, in this case he’s telling folks to just buy the shares for a lower-risk trade … so I thought y’all might be interested.
Paul Tracy runs the StreetAuthority Market Advisor newsletter, and he has an ad out now about investing only in stocks that have a “driving force” behind them.
He doesn’t mean any technical indicators, or fundamental financial forces, he means catalysts. Catalysts are, of course, the great holy grail of “story” investing — when you buy most biotech stocks, for example, you’re looking for a “catalyst” to drive the shares higher in the form of an FDA approval or a buyout. You’ll hear pundits like Jim Cramer talk about catalysts all the time, too — there are a lot of folks who might be excited about a stock’s valuation or prospects, but are unwilling to buy it if they don’t see an event in the near future that should move the stock abruptly higher (or lower, one must add).
So what are the “catalyst” stocks that Tracy thinks you should look at now?
Tim Fields is telling us that the next big wave will be personalized medicine, and using genetic testing to customize treatments. We’ve heard that before from several newsletter editors, and it has been an investment theme for years. Will this little stock really revolutionize medicine and lead to untold riches for investors? First, I’ve got to figure out who it is for you.
The Motley Fool is sending out an ad that claims to have chosen “The Only Stock to Own 2009-2019.” Now there’s a promise, no? The assumption of almost all pundits and pontificators, myself included, is that this awful market might represent a remarkable buying opportunity — at least, an opportunity for those who make the […]
The merry lads at the Oxford Club are at it again, promoting their subscription service with a nice long teaser ad that promises to turn you on to the next hot investing strategy. And as usual, there’s a little truth and a lot of obfuscation — so let’s give it a look. Here’s how they […]
And so it begins — with every significant social change, every newsletter and investment service has to come out with a teaser list of the “top ten” or the “three to buy now” or, in this case, the five stocks you must buy to be prepared to profit in an Obama presidency. New presidential administrations […]
Last week I got an email ad from Robert Hsu telling me with an encouraging sentence hidden in the middle: “After today, I feel more confident that we have seen the lows for the year.” That was on Thursday, October 30, and the encouraging point Hsu was pointing to was the big bounce on Tuesday, […]
OK, so my ancestry is mostly Swedish, and I can’t help but think of a smorgasbord when I see the latest email out from Louis Navellier for his Blue Chip Growth newsletter. If you don’t know what a smorgasbord is, it’s basically a big buffet layout of Swedish foods, often served at holidays. And like […]
I haven’t written much about Robert Hsu and his China Strategy newsletter lately, but back when China’s markets were shooting out the lights last year he was probably the most popular newsletter editor out there. This year has seen a reversal of so many different Chinese stocks, and a loss of faith in the China […]
If you’re not an analyst or asset manager who specializes in the financial sector, and you don’t count on AIG, Lehman Brothers, or their many near competitors for a paycheck, right now might be a good time to take a step back, breathe a little, and thank whatever deity or lucky totem you might carry, […]
This is part of an ad that we’ve looked at before in slightly different form — the other “Billion Dollar SSE” we looked at was General Steel Holdings back in July. What the folks at the Motley Fool’s Global Gains newsletter mean when they call something a “SSE” is a “state sponsored entrepreneur” or “state […]
This is a little weekend refresher, for folks who might have missed the writeup the first time around. Robert Hsu has been touting a Canadian oil sands stock that is a play on China, since China is interested in buying their product or partnering with them. And the company is a better buy now than […]
My confidence in the long-term potential for Seadrill remains unshaken, but the price has certainly taken a hit in the last week (and the last two months). I think all the major offshore drillers are unbelievable bargains at this point, since they have fabulous earnings visibility out several years regardless of the oil price (these […]
Greetings from the road, everyone — my time is limited today so I’m sharing a very interesting comment that a reader sent in … we’ll call him Carlo. Carlo looked into Louis Navellier’s recent history with the formerly highflying Russian steel (and coal) stock, Mechel (MTL). This was also a Robert Hsu pick for a […]
Apologies for folks who are seeing this comment a second time, but the site had severe server problems yesterday and was down for much of the day — so I’m republishing it to make sure that you have a chance to read this note if you want to. This is not going to be a […]
Recent Comments
What's more interesting and leads credibility to this line of thought that Teeka did disclose and that the publisher was aware of it were Teeka's recent comments (post being fired)…...
Travis, what is the stock symbol for Saturnose in India? Thank you. Please send me an email jyhsu@calpoly.edu...
Would appreciate the info lalgulab12. Thanks. apexhealthsupplies@gmail.com...
Lisa, so sorry for your spinal problems, my wife had pain management also which became complicated by many ailments & finally early onset dementia. I have an aversion to pain…...
Unknown scientific source of "fully vaccinated can still carry & unknowingly spread the China virus" might consider NASA retail website for reconditioned "suits" & then his congressman as to funding…...
Doc, you had an interesting swerve from research "chain" you started w/ to basically political intimations & purely speculative hindsight projections of which the "govt/virologists" live by. The call for…...
NNDM. Good interview with CEO. I be live revenue will definitely come post covid. https://www.globenewswire.com/Tracker?data=4d0i9E5fvxG7Y9rsJCbKtBROF1DnzeKTzyP2x30cWj4hYYeU6qugzNc63a5qwagI66aop9A_yAjiUoGAB1tcl0QcHSUmxbtTTOXOqs-cL2zVLTmooPgoXLiGjUWAUwpFs9eWQFfIp7wFxlT1OVJrMXGUqbYLnpupWaNw7JlaH2KEUTVLuIpZ9lgkfGftJ4OZAfxNx1zgdJfSUY8WIHUAqgAqqGo8H_1C0reQ6ef3wgBwwIV8ivCpkGUAu3MJ4osQ3AuvZCCV6jIstevMNR39FNkc34Zrwt1EVH_OlflDFqgZV_aX6SPiBPRsioxShkmPAhhnT2I4_yXpGqIF90e95CNmDc-uLqmR2slFns7potIRkFaBtoZE3Lzdh6_QlYkJ0uzuWgSuaUDVK127JWTAMEnAbjCmJc6AITkYShqEI4sdDXV39MGlf_w2PQu4CdDQDKXRXnmIdrMFqzmwr3fkUMTSwY-nSPZrOQw8PHwLlv8=...
Today aitx is sitting at 0.25 and looks like they have a deal with CVS Pharmacy for one of their devices. If it works out more major retailers could follow....
DDD @ $10, not $6.50. There had been talk of a Musk buy. Chart reading says $14-$20 best case.& $12 very soon....
Brilliant analysis as usual. Thank You for the incredible work, in breaking this mystery down, and thank God you own the incredible Thinkolator. And LOVE the humor mixed in to…...
Yikes,..you lost me at Zach Scheidt. ....To be fair,....his last ten stock picks have been DOGS !!! Each has lost over 50 cents in the first few days of his…...
I always run in the opposite direction when guru jeff brown says to buy a stock. You might ask why,....fair enough question. After getting Scorched on 3 of his last…...
Not a big fan of Zach Scheidt. Was a sucker and paid $2,500. for 2 years of his "Buyout Millionaire Club". Huge mistake. He promised over & over he was…...
But it's a 10 bagger from here! Don't you know ? ;)...
I think you hit nail on the head with your assessment. He claims to be investing in biotech for years yet he doesn't have any money. I really think the…...
The problem here is we are hearing only one side of the story. I am sure there is a lot jucy details behind the scenes that we're not privy to…...
So already quite a few here have exactly the same experience. I wonder who are these people that benefited from these biotech "tips" (he doesn't give investment advice but everyone…...
Yeah in my case "investing" in biotech is not worth the hassle of staying up to date with all developments and sleepless nights if you're sitting on a fairly big…...
I am glad I sold most of my biotech stocks, at a loss but would have been an even bigger loss now. I have a tiny position in $FCSC, small…...
That is "investing" in biotech in essence for you. Now that he has started pushing even smaller penny stock preclinical companies it's going to get worse. It's best to realise…...
From what I heard he is not allowed to talk about ARCH anymore if he wants to stay in KSS's good graces so little chance of him appearing on these…...
Nice try...
Looks like it was TGODF. Paul makes his announcements at 10:30 am. And their stock surged about 8% a couple minutes afterwards.. largest volume in quite some time. Might buy…...
Released today, the regulators will announce a plan to end conservatorship. Up 34% today....
Where might I find the better annual rate?...
Travis commented briefly last week and his thoughts were it was most likely Fanney Mae. I bought 5000 shares Monday, it was really cheap, $1.25. It’s up nearly 50%, wish…...
Fannie Mae is up almost 50% since Monday. I bought 5000 shares after reading Travis’s comment, wishing now I’d been a little bolder!...
3 levels of membership. 1yr 100% money back guarantee........Just listened to promo & am waiting for c/b as to type of trade, etc......will add more later..........
Thank you ! Computer NOVICE here. I was watching it and was half-hooked when I got a phone call and left, & it went off the screen. In searching for…...
I remember shark tanks Mark Cuban liking NVidia. Their chips are the leaders in AI. Jen-Hsun Huang Owns about 20 million shares. If the stock goes to 50,000, he’d be…...
Just listened to the 9/26 @4pm online presentation. Says he'll answer questions, but doesn't. Asked how he chooses analyst which is primary to the "Catalyst Alert" program who seem to…...
What you have described is exactly my experience and I presume a lot of other people having a long term view. I think you have two choices if you are…...
I am beginning to think that there is no winning in this sector for a casual retail investor unless you take part in the private placement with a lot better…...
$CYDY np Does anyone still follow a story of CytoDyn? They have reached a primary endpoint in their phase2b/3 study on the partial data (27 patients out of 50 if…...
TMUS (T Mobile apparently is merging/buying Sprint (S) & both have large commitments to 5G). Nice upward arc after initial fall from merger announcement.......Likely to continue even more sharply upward..........
I remember talking w/ a "former" Motorola "engineer" back in '88 who said, "Don't buy a handheld cell/ph, stay w/ the bag phone due to the "waves" damaging the brain!!"…...
Why was my 2nd response as to Verizon w/held????...
As a former "cable" contractor back in it's infancy, I, too, am enamored w/ LEO & logically think why "dig & string"......I continue to sniff @ anything "LEO"......makes more sense…...
I read Travis & this is 1st time I remember ANY politics mentioned. I, too, am sensitive to the massive negative energy directed @ "ALL THINGS TRUMP" & didn't understand…...
Hi. I've been through this pain (I live in the UK). Had an account with DeGiro and SVS and in the end transffered the whole portfolio to Interactive Brokers and…...
$APTO NEWS RELEASES 4/16/18 OHSU and Aptose Present New CG'806 Preclinical Data at 2018 AACR Annual Meeting http://phx.corporate-ir.net/phoenix.zhtml?c=116148&p=irol-newsArticle&ID=2342649 4/16/18 Aptose Presents New Preclinical Data on CG'806 Pan-FLT3/ Pan-BTK Inhibitor at…...
$APTO wow - Title: Aptose Presents New Preclinical Data on CG'806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting Date(s): 16-Apr-2018 7:30 AM For a complete listing of our news…...
THanks, I dont believe that Cleveland gave a concrete rebuttal that disproved watermaven. BOth watermaven and cleveland were arguing over personal opinions based on deductive reasoning. THAT was my conclusion…...
Sounds like enviro/cleanup is a growth industry?...
$arth long I'm sorry sir but what did watermaven say that was wrong or untrue? I found what he wrote to be credible and honest. He said he believed the…...
#ThankYOU Robert, Chet and others for sharing... :-) InMed Appoints Dr. Eric Hsu as Vice President, Preclinical Research and Development March 13, 2018 Vancouver, British Columbia, Canada – March 13,…...
$CLSD Totally agree. Bottom fishing is the name of the game here in the bio world. Best example is the latest development with $ESPR. Good top line phase 3 data…...
$REPH long normal position I have been in and out of Recro but thinking of riding it out until approval. The thing that worries me slightly is lack of general…...
STM thanks for the update. From the stocks from your portfolio i have an observation and potential income earner. $CLRB was beaten down badly and seemed to have bottomed. I…...
Re: margin account I do have one with IB and basically it gives you the ability to a) purchase stock on loan (margin) and b) short sale equities. There is…...